Swan Energy Consolidated September 2023 Net Sales at Rs 1,223.26 crore!
Thu, Nov 23, 2023 12:42 PM

Swan Energy Consolidated September 2023 Net Sales at Rs 1,223.26 crore!

A Flip by Avya Verma
Get it on Google Play
Reported Consolidated quarterly numbers for Swan Energy are: Net Sales at Rs 1,223.26 crore in September 2023 up 752.62% from Rs. 143.47 crore in September 2022. Quarterly Net Profit at Rs. 84.58 crore in September 2023 up 364.66% from Rs. 31.96 crore in September 2022. EBITDA stands at Rs. 263.81 crore in September 2023 up 6716.8% from Rs. 3.87 crore in September 2022.

More great flips

Muthoot Finance's arm Belstar Microfinance files Rs 1,300-cr IPO papers

Muthoot Finance's arm Belstar Microfinance files Rs 1,300-cr IPO papers

Muthoot Finance’s microfinance arm, Belstar Microfinance Ltd, on Sunday filed preliminary papers with capital markets regulator Sebi to raise Rs 1,300 crore through an initial public offering (IPO). The Chennai-based entity’s IPO is a combination of fresh issue of equity shares worth Rs 1,000 crore and an offer-for-sale (OFS) of Rs 300 crore by investor shareholders, according to the DRHP.

Open Flip
Where to look for new opportunities in this expensive market?

Where to look for new opportunities in this expensive market?

It is no secret that, on an aggregate basis, broader space is trading at an extremely expensive multiple (over 33 times on a trailing basis for BSE Small-cap index). In an expensive market, hidden opportunities exist despite high valuations. AMCs offer potential post sector rerating. Discounted prospects like UTI and ABSL present favorable entry points for investors eyeing long-term growth.

Open Flip
Cipla, Glenmark recall drugs from US market: USFDA

Cipla, Glenmark recall drugs from US market: USFDA

Drug makers Cipla and Glenmark are recalling products from the American market due to manufacturing issues, according to the US health regulator. As per the latest Enforcement Report issued by the US Food and Drug Administration (USFDA), a New Jersey-based subsidiary of Cipla is recalling 59,244 packs of Ipratropium Bromide and Albuterol Sulfate Inhalation Solution.

Open Flip

Join our Smart Investment Community

More than 1 Million users are using FlipItMoney to stay updated about the business and finance world! Join FlipItMoney now and take smart investment decisions!
Icon